ALSO READ: Canada: Random Covid testing will resume for international travellers The House panel said J&J told it that a batch of the shots failed inspection, which rendered all of them unusable.
According to South Carolina Democrat and COVID-19 subcommittee chairman Jim Clyburn, the factory's problems have hurt vaccinations in areas of the world where vaccines are still in short supply.
Meanwhile, Emergent said it has been 'open and forthcoming' about the factory's challenges. It also noted that J&J took control of the plant after problems first emerged and was in charge until manufacturing stopped there earlier in 2022.
The Food and Drug Administration (FDA) initially shut down the problem-plagued Baltimore factory in early 2021 due to contamination.